Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer
Abstract Background Paclitaxel induced peripheral neuropathy (PIPN) is a major debilitating side effect of paclitaxel in patients with breast cancer with no fully known mechanisms. The aim of the study was to find out the possible risk factors for PIPN. Methods Eligible patients with node positive b...
Main Authors: | Zohreh Ghoreishi, Seyedali Keshavarz, Mohammad Asghari Jafarabadi, Zahra Fathifar, Karyn A Goodman, Ali Esfahani |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-10-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-018-4869-5 |
Similar Items
-
Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: A randomized double-blind placebo controlled trial
by: Ghoreishi Zohreh, et al.
Published: (2012-08-01) -
Acupuncture for Paclitaxel-Induced Peripheral Neuropathy: A Review of Clinical and Basic Studies
by: Zhao YX, et al.
Published: (2021-04-01) -
Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity
by: Kuniaki Tsutsumi, et al.
Published: (2016-06-01) -
A Fenofibrate Diet Prevents Paclitaxel-Induced Peripheral Neuropathy in Mice
by: Martial Caillaud, et al.
Published: (2021-12-01) -
Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy
by: Takehiro Kawashiri, et al.
Published: (2021-08-01)